drugset / Trial / NCT06938880
Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
This trial is designed to assess the tolerability, safety, pharmacokinetic profile, and preliminary efficacy of the combination of ZGGS18 and ZG005 in patients with advanced solid tumors, including advanced cervical cancer, hepatocellular carcinoma, neuroendocrine cancer, and lung cancer.
Timeline
- Start
- 2025-05-20
- Primary completion
- 2027-05
- Completion
- 2028-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZG005 | Unknown | 10 mg/kg | Intravenous |
| Subject | ZG005 | Unknown | 20 mg/kg | Intravenous |
| Subject | ZGGS18 | Unknown | 10 mg/kg | Intravenous |